Posts by Emily Waller
One step closer to progress: Rare Cancers Bill passes Third Reading
Last week, the Rare Cancers Bill was under threat – but thanks to our amazing supporters, we saved it! The Bill passed its final debate (known as the Third Reading) in the House of Commons, marking another significant step in its journey through Parliament.
APPG on Less Survivable Cancers: 6 month update
Pancreatic Cancer UK is proud to be acting as the Secretariat for the All-Party Parliamentary Group (APPG) on Less Survivable Cancers. Launched in January, the APPG has had an action-packed first few months. Here’s an update on its activity so far with plenty more to come…
A huge step forward for the Rare Cancers Bill
We're delighted that the Rare Cancers Bill is successfully continuing its passage through Parliament.
Liberal Democrats commit to action on the less survivable cancers – our response
Read our response to the Liberal Democrats' commitment to a new Cancer Survival Research Act.
UK Government publish Urgent & Emergency Care Recovery Plan – our response
Our Director of Research, Support and Influencing comments on the publication of the government's Urgent and Emergency Care Recovery Plan.
Welsh Government publish new Cancer Improvement Plan for NHS Wales
Our Director of Support, Research and Influencing, Anna Jewell, comments on the publication of Wales' new Cancer Improvement Plan.
Government U-turn on publication of 10 Year Cancer Plan – our statement
Pancreatic Cancer UK's Director of Support, Research and Influencing, Anna Jewell, comments on the government's decision to scrap the 10 Year Cancer Plan for England
MPs’ letter to send to the Health Secretary
The Government are writing a new 10-year Cancer Plan, and as an MP you can help us ensure that pancreatic cancer has an important place in it.
Our open letter to Jo Churchill, Cancer Minister for England
An open letter to Jo Churchill, the Cancer Minister, raising our concerns about how COVID-19 is impacting pancreatic cancer treatment and care.
Spending Review 2020: A missed opportunity to stand up for medical research
Our CEO, Diana Jupp's statement on the 2020 Spending Review